Press release

DSM completes sale of participation in DEXPlastomers JV to Borealis

Heerlen, NL, 04 Mar 2013 08:15 CET

Royal DSM, the global Life Sciences and Materials Sciences company, announced today that it has completed the sale of its participation in DEXPlastomers V.o.F, a 50/50 Joint Venture of DSM with an affiliate of ExxonMobil Chemical, to Borealis. DSM also sold its LldPE Compact Solution Technology to Borealis. The transaction was announced in November 2012.

Established in 1996, DEXPlastomers is a 50/50 joint venture between DSM and Exxon Chemical Holland Ventures B.V., producing C8 plastomers and linear low density polyethylene. In the scope of the transaction are approximately 100 employees who have transferred to the new owner upon closing. DSM’s LldPE Compact Solution Technology was first developed in the 1960’s to produce polyethylenes in a certain density range and is instrumental to the operations of DEXPlastomers.

For DSM, a sale of DEXPlastomers is in line with its long-term focus of being a Life Sciences and Materials Sciences company, active in health, nutrition and materials. DSM’s 50% participation in DEXPlastomers was reported under Corporate Activities in DSM’s accounts.

For more information

Lieke de Jong-Tops

Senior Communications Manager
+31 45 578 2420

Dave Huizing

Vice President Investor Relations
+31 45 578 2864

Media Relations

+31 45 578 2420

Investor Relations

+31 45 578 2864